Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
€ 1.4
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
NanoRepro AG develops, manufactures, and distributes rapid diagnostic tests and food supplements for home and professional use in Germany and internationally. It provides products in the areas of family planning and disease detection, as well as food intolerances, allergies, and infectious diseases. The company offers rapid diagnostic tests, including allergy, family planning, and preventive healthcare...
Company Valuation
Considering past and projected metrics, the stock is 'cheaper' than its peers. In particular, the stock is undervalued on P/FCF.
Data is available to registered users only
Buy
Sell